Page 9 - Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Commodore capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Commodore Capital Today - Breaking & Trending Today

Commodore Capital LP Raises Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Commodore Capital LP boosted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 610,000 shares of the biotechnology company’s stock after buying an additional 35,000 shares during the period. Arrowhead Pharmaceuticals accounts […] ....

United States , Christopher Richard Anzalone , Advisors Asset Management Inc , Star Investment Management Corp , Morgan Stanley , Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Stock Down , Lazard Asset Management , Quarter For Arrowhead Pharmaceuticals , Royal Bank , Arrowhead Pharmaceuticals Profile , Arrowhead Pharmaceuticals Inc , News Ratings For Arrowhead Pharmaceuticals Daily , Exchange Commission , Commodore Capital , Free Report , Star Investment Management , Asset Management , Financial Advisors , Pharmaceuticals Stock Down , Richard Anzalone , Martin Javier San , Arrowhead Pharmaceuticals Daily , Nasdaq Arwr , Sec Filings , Hedge Fund Holdings ,

Commodore Capital LP Buys 35,000 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Commodore Capital LP grew its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% during the second quarter, Holdings Channel.com reports. The fund owned 610,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 shares during the quarter. Arrowhead Pharmaceuticals makes up 2.4% of Commodore Capital LP’s investment portfolio, making the […] ....

United States , Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Trading Down , Advisors Asset Management Inc , Morgan Stanley , Royal Bank , Quarter For Arrowhead Pharmaceuticals , Thrivent Financial For Lutherans , Holdings Channel , News Ratings For Arrowhead Pharmaceuticals Daily , Proshare Advisors , Arrowhead Pharmaceuticals Inc , Commodore Capital , Free Report , Financial Advisors , Asset Management , Share Advisors , Pharmaceuticals Trading Down , Martin Javier San , Director Victoria Vakiener , Visit Holdingschannel , Arrowhead Pharmaceuticals Daily , Nasdaq Arwr , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Bought by Commodore Capital LP

Commodore Capital LP boosted its position in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 35.6% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,348,272 shares of the company’s stock after acquiring an additional 616,907 shares during the quarter. Enliven Therapeutics comprises […] ....

United States , Samuel Kintz , Partners Vi Llc , American International Group Inc , Enliven Therapeutics Inc , Fairmount Funds Management , Securities Exchange Commission , York Mellon Corp , Life Insurance Co , Commodore Capital , Enliven Therapeutics , Free Report , Funds Management , International Group , New York Mellon Corp , Global Management , Exchange Commission , Get Free Report , Enliven Therapeutics Daily , Nasdaq Elvn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

775,000 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Purchased by Commodore Capital LP

Commodore Capital LP purchased a new position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 775,000 shares of the company’s stock, valued at approximately $18,212,000. IDEAYA Biosciences comprises approximately […] ....

United States , Dekabank Deutsche Girozentrale , Royal Bank , Goldman Sachs Group , American International Group Inc , Jpmorgan Chase Co , Securities Exchange Commission , Biosciences Inc , Swiss National Bank , Ziegler Capital Management , Commodore Capital , Free Report , Bank Deutsche Girozentrale , Capital Management , International Group , National Bank , Trexquant Investment , Stock Down , Get Free Report , Jason Throne , Exchange Commission , Visit Holdingschannel , Ideaya Biosciences , Nasdaq Idya , Sec Filings , Hedge Fund Holdings ,

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Acquired by Commodore Capital LP

Commodore Capital LP increased its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 112.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,675,000 shares of the company’s stock after purchasing an additional 885,000 shares during the quarter. Akero Therapeutics comprises approximately 8.8% of Commodore Capital LP’s portfolio, making the stock […] ....

United States , Jonathan Young , Andrew Cheng , Morgan Stanley , Osaic Holdings Inc , Life Insurance Co , Akero Therapeutics Inc , Us Bancorp , Securities Exchange Commission , Jpmorgan Chase Co , Royal Bank , Cantor Fitzgerald , Commodore Capital , Akero Therapeutics , Free Report , Retirement System , Get Free Report , Exchange Commission , Visit Holdingschannel , Akero Therapeutics Daily , Nasdaq Akro , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,